about
Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletionOsteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesHuman papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcriptionThe expression and significance of IDH1 and p53 in osteosarcomaRetention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.Accommodating haploinsufficient tumor suppressor genes in Knudson's model.Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP)Hepatitis B virus infection and primary hepatocellular carcinoma.Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemiaAbsence of hereditary p53 mutations in 10 familial leukemia pedigrees.Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein.A DNA binding domain is contained in the C-terminus of wild type p53 proteinThrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient miceWidespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric RhabdomyosarcomaActivating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patientsPrognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumoursp53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistryPrognostic significance of p53 overexpression and mutation in colorectal adenocarcinomasMutational status of K-ras and TP53 genes in primary sarcomas of the heartGenetics of Bladder Malignant Tumors in ChildhoodAnalysis of p53 mutants for transcriptional activity.Osteosarcoma development and stem cell differentiationDual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signalingMalignant transformation of human fibroblast cell strain MSU-1.1 by (+-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene.Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.p53 in chronic myelogenous leukemia in acute phase.Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.Mutations in p53 as potential molecular markers for human breast cancer.
P2860
Q24564365-A5158A58-4330-4BFD-86C8-2017AC5ACE90Q26782646-7BCB2EFD-843D-4C63-BDCB-1701F1B90AE7Q28187745-32CAAE83-269A-41BE-8305-415B6A86524EQ33864108-0D553087-AE3E-4D23-9A21-777D5B8790DCQ33889285-4542877E-0DD4-4E1C-9309-AA22D109EEE8Q33938629-2DBD540C-73A1-402C-BD81-5B67F8F6F3BDQ33986221-3513A314-2A4F-45E7-BB08-A65D3094F8C7Q34091728-D87219FC-E9D5-4044-ADC4-62A515894DDDQ34162514-F622E59C-1EFD-4C6C-8704-FFEBE14522F5Q34207682-E27C9EEA-DEA0-419D-9322-4F54FEC378E3Q34674371-7E1CC318-1456-4695-A0E8-984DFE2374E4Q35194785-82109DEB-78BA-46F7-BE08-D7E1C16A37C1Q35231554-F9CB10C3-DF3A-482E-9C17-E52EF0313121Q35598211-3D528973-FEB9-4528-AA9C-5EF94387E61EQ35605819-E033192B-5D8F-4A62-A4F9-BFA5E569E37AQ35782214-EE95ABF3-D897-45AA-86B3-3AA86CA3124DQ35782290-DB80C47F-EBEF-4704-BE55-5F345DF6D179Q35785411-2D4F1980-23F8-4C19-B6E5-4EC5E141432DQ35788429-5718279E-8C2D-4E56-A2A2-2F83EAFB4D77Q35830939-A6285599-A686-4A8C-B504-1BA067CC06A6Q35833993-0C7D0C09-CBF6-45C7-990B-F7647B8718EDQ35897781-1E3D56BA-62A1-4739-A871-63BC7264DBB9Q35936863-E9DBF327-FA7C-470C-83BC-C7BDAD8B68C7Q35978175-D924B582-958C-4633-BF32-C2966177EF4FQ35994127-3EC5C809-F9E3-439E-B93A-9B2C66B6783FQ36134424-497212D1-1D4D-4CD6-B5EC-1B2B6AA4E1A4Q36135501-DF205C2F-8193-43E6-8CA2-1BEB0799A329Q36621284-E7C7F143-1C89-48F5-B39D-66E475AC12EAQ36658484-1224CB72-7A85-4597-8701-B4AC0D195544Q36743632-D6E327C0-78EE-4591-A0F2-F28480F7FA41Q36803600-5545AF4C-1B1A-4529-9FA0-195879062899Q36888312-C526CFE8-D74C-4204-B4D8-F09B311E0E9EQ36890073-20EAF555-2642-458D-87EE-ED43D4B052D3Q37032121-4B798768-3C1E-4096-A8C2-335A883932E4Q37421517-1298533B-2D4B-4842-AC11-1D49DE7ED2DEQ37500547-BB255A6F-AE20-4AEA-8E5B-206C042DF179Q37550931-AB011739-AC84-4ED4-B83F-FBFC00EF009FQ37597399-EDC8C89E-0A66-4395-8AAC-4896CB9AC1F8Q37600408-3255D0AD-E2C1-41E0-8602-8686AD26407BQ37632816-7B05C54C-9B9C-441B-A5FD-DB4296937DE6
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Mechanisms of p53 loss in human sarcomas.
@ast
Mechanisms of p53 loss in human sarcomas.
@en
type
label
Mechanisms of p53 loss in human sarcomas.
@ast
Mechanisms of p53 loss in human sarcomas.
@en
prefLabel
Mechanisms of p53 loss in human sarcomas.
@ast
Mechanisms of p53 loss in human sarcomas.
@en
P2093
P2860
P356
P1476
Mechanisms of p53 loss in human sarcomas.
@en
P2093
Cavenee WK
Matlashewski GJ
Mulligan LM
Scrable HJ
P2860
P304
P356
10.1073/PNAS.87.15.5863
P407
P577
1990-08-01T00:00:00Z